发明名称 | Methods of treatment of histamine H-4 receptor-related pruritus | ||
摘要 | The methods disclosed herein relate to the treatment of histamine H-4—related pruritus, by administering a histamine H-4 receptor inverse agonist that selectively accumulates at the biophases of the disorders, specifically RS-norketotifen or a pharmaceutically acceptable salt thereof. Potentiated antipruritic activity by simultaneous inhibition of histamine H-1 receptors and histamine H-4 receptors are described. | ||
申请公布号 | US9138431(B2) | 申请公布日期 | 2015.09.22 |
申请号 | US201313960114 | 申请日期 | 2013.08.06 |
申请人 | BRIDGE PHARMA, INC. | 发明人 | Aberg A. K. Gunnar;Ciofalo Vincent B. |
分类号 | A01N43/40;A61K31/445;A61K31/4535 | 主分类号 | A01N43/40 |
代理机构 | Cantor Colburn LLP | 代理人 | Cantor Colburn LLP |
主权项 | 1. A method of treating a mammal with selective inverse histamine H-1 agonists, and wherein the histamine H-4 receptor-related pruritus is associated with a dermal disorder selected from autoimmune dermatitis, contact dermatitis, dermal scleroderma, folliculitis, an insect bite, melanoma, parasites, scabies, sunburn, warts, xerosis, moles, and idiopathic pruritus. | ||
地址 | Sarasota FL US |